Dr. Michael R. Mirhadi, MD

Dr. Mirhadi practices at Mercy Hospital of Folsom in Folsom, California, part of CommonSpirit Health.

Dr. Mirhadi's NPI, 1194909457, was assigned on December 21, 2007. Dr. Mirhadi graduated from Albany Medical College in 2006. Dr. Mirhadi holds California license NONE.

Dr. Mirhadi's primary practice is Mercy Hospital of Folsom, at 1650 Creekside Drive, Folsom, CA 95630 in Sacramento County. The practice phone is (916) 983-7400.

Dr. Mirhadi's primary practice is Mercy Hospital of Folsom in Folsom, California, part of CommonSpirit Health. Dr. Mirhadi is also affiliated with UCI Health - Orange. The medical group on file is Vituity. Dmand AI also links Dr. Mirhadi to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mirhadi practices, 3 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Mirhadi's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Mirhadi is board certified in emergency medicine by the American Board of Emergency Medicine. Dr. Mirhadi is licensed in California.

CMS data shows 757 Medicare services from Dr. Mirhadi across 5 procedure codes in 2024, for 665 Medicare patients. Medicare paid $86,749 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 665 Medicare patients who saw Dr. Mirhadi in 2024. The largest group is 75 to 84, with 230 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mirhadi's median patient age at 46, with 58% women.

In 2024, Dr. Mirhadi wrote 224 Medicare Part D claims for 180 patients. 94% of them were for generic drugs. CMS names the drug for 98 of them, across 5 drugs with 11 or more claims each, at $499 in total drug cost. In 2023, CMS named 108 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Mirhadi for performance year 2024, reported as part of a group. Dr. Mirhadi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Dr. Mirhadi from 2 drug and device companies from 2018 to 2020. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $46.

Dr. Mirhadi graduated from Albany Medical College in 2006.

Dr. Mirhadi is in network with 3 carriers, including United Healthcare, CMS Medicare and HCSC. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.